Manzo et al. describe the development of multiple pleurocidin analogues with substantially improved antibacterial properties, conformational flexibility and therapeutic efficacy against murine models of bacterial lung infection. The most promising analogue is as effective as vancomycin in an in vivo mouse EMRSA lung model.
- Giorgia Manzo
- Charlotte K. Hind
- A. James Mason
